Literature DB >> 34431044

MiR-1273 g-3p Promotes Malignant Progression and has Prognostic Implications in Prostate Cancer.

Yaxue Chang1, Qian Deng2, Zhenfeng Guan2, Yongyi Cheng2, Yi Sun2.   

Abstract

Prostate cancer (PCa) is the most popular cancer of mankind. Our study aimed to provide the expression and the predictive significance of miR-1273 g-3p in PCa. Moreover, the effects on cell biological activities were also investigated. The relative expression of miR-1273 g-3p in PCa tissues and cell lines was validated by quantitative real-time PCR. Kaplan-Meier curve and Cox regression analyses were performed to indicate the prognostic value. The implications of miR-1273 g-3p on cell proliferation, migration, and invasion were validated using the CCK-8 and Transwell assay. Our results provided that the expression of miR-1273 g-3p was increased in PCa tissues and cell lines. The levels of miR-1273 g-3p were associated with Gleason score, TNM stage, clinical stage, and lymph node metastasis. Overexpression of miR-1273 g-3p indicated a promising overall survival rate. Cox regression results indicated miR-1273 g-3p might be an independent marker for PCa patients. Silenced miR-1273 g-3p inhibited PCa cell proliferation, migration, and invasion. In total, miR-1273 g-3p was increased in PCa and identified as a therapeutic target and a prognostic factor for PCa patients. Overexpression of miR-1273 g-3p might be an oncogene via accelerating cell proliferation, migration, and invasion.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Invasion; Migration; Prognosis; Proliferation; Prostate cancer; miR-1273 g-3p

Mesh:

Substances:

Year:  2021        PMID: 34431044     DOI: 10.1007/s12033-021-00384-x

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  25 in total

Review 1.  Post-transcriptional gene silencing by siRNAs and miRNAs.

Authors:  Witold Filipowicz; Lukasz Jaskiewicz; Fabrice A Kolb; Ramesh S Pillai
Journal:  Curr Opin Struct Biol       Date:  2005-06       Impact factor: 6.809

Review 2.  Current drug therapy for prostate cancer: an overview.

Authors:  Alistair B Stewart; Bashir A Lwaleed; David A Douglas; Brian R Birch
Journal:  Curr Med Chem Anticancer Agents       Date:  2005-11

3.  Lifestyle and dietary factors in prostate cancer prevention.

Authors:  Andrea Discacciati; Alicja Wolk
Journal:  Recent Results Cancer Res       Date:  2014

4.  Familial prostate cancer.

Authors:  Veda N Giri; Jennifer L Beebe-Dimmer
Journal:  Semin Oncol       Date:  2016-08-18       Impact factor: 4.929

Review 5.  Prostate Cancer Genetics: Variation by Race, Ethnicity, and Geography.

Authors:  Timothy R Rebbeck
Journal:  Semin Radiat Oncol       Date:  2016-08-26       Impact factor: 5.934

Review 6.  Prostate Cancer Disparities by Race and Ethnicity: From Nucleotide to Neighborhood.

Authors:  Timothy R Rebbeck
Journal:  Cold Spring Harb Perspect Med       Date:  2018-09-04       Impact factor: 6.915

Review 7.  Assessment of miR-98-5p, miR-152-3p, miR-326 and miR-4289 Expression as Biomarker for Prostate Cancer Diagnosis.

Authors:  Leire Moya; Jonelle Meijer; Sarah Schubert; Farhana Matin; Jyotsna Batra
Journal:  Int J Mol Sci       Date:  2019-03-06       Impact factor: 5.923

8.  Identification of non-invasive miRNAs biomarkers for prostate cancer by deep sequencing analysis of urinary exosomes.

Authors:  Marta Rodríguez; Cristina Bajo-Santos; Nina P Hessvik; Susanne Lorenz; Bastian Fromm; Viktor Berge; Kirsten Sandvig; Aija Linē; Alicia Llorente
Journal:  Mol Cancer       Date:  2017-10-05       Impact factor: 27.401

9.  Increased expression of miR-153 predicts poor prognosis for patients with prostate cancer.

Authors:  Cheng-Wei Bi; Guo-Ying Zhang; Yu Bai; Bin Zhao; Hong Yang
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

10.  Influence mechanism of miRNA-144 on proliferation and apoptosis of osteosarcoma cells.

Authors:  Xu Zhang; Zhengwei Li; Wei Ji; Xilong Chen; Qiang Gao; Dajin Li; Haihui Qin
Journal:  Oncol Lett       Date:  2019-12-10       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.